IOVA
Iovance Biotherapeutics Inc
$14.45
3.46 (31.48%) Today
0.02 (0.14%) After-hours
— up— down
Market Cap
$6.55B+548.0%
Revenue (TTM)
$322.33M+34.5%
Net Income (TTM)
$-321,971,150
$-321,971,150EPS (TTM)
-0.72
-0.72Shares Out
446.50M
446.50MOpen
$14.45
$14.45Previous Close
$10.99
$10.99Day Range
$12.78 – $15.30
$12.78 – $15.3052-Week Range
$1.76 – $15.30
$1.76 – $15.30Beta
0.87
0.87Volume
78.03M
78.03MAvg Volume
15.78M
15.78MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
Related
News
N/AN/A
N/AN/A
Iovance Biotherapeutics (IOVA) Eyes 60% Revenue Growth, Shares Jump 31%
Yahoo · 6h ago
Apple, Meta, Iovance, Carnival, Fair Isaac, Bloom Energy, SpaceX, and More Stocks That Explain Today’s Market
Yahoo · 9h ago
Iovance: The Turnaround Is Priced In, Downgrading To Hold
SeekingAlpha · 14h ago
Iovance Stock Surges as Strong Melanoma Drug Demand Drives Growth
Yahoo · 14h ago
IOVA Stock Hits Over 2-Year Highs – Why Iovance Raised Its FY2026 Revenue Outlook
Yahoo · 16h ago